Mark Currie

Mark Currie

Director/Board Member at IRONWOOD PHARMACEUTICALS, INC.

Net worth: 2 M $ as of 31/05/2026

71 year
Health Technology
Commercial Services
Consumer Services

Profile

Mark G.
Currie
currently works at Science Exchange, Inc., as Director from 2020, Antag Therapeutics ApS, as Director, Sea Pharmaceuticals LLC, as Director from 2021, Ironwood Pharmaceuticals, Inc., as Independent Director from 2019, and Iaso Ventures LP, as Partner.
Dr. Currie also formerly worked at Monsanto Co., as Director-Arthritis & Inflammation, G.D.
Searle & Co., Inc., as Director-Arthritis & Inflammation, Sumitomo Pharma America, Inc., as Vice President-Discovery Research from 1999 to 2002, Ironwood Pharmaceuticals, Inc., as Chief Scientific Officer, President-R&D, Senior VP from 2002 to 2019, and Cyclerion Therapeutics, Inc., as President & Chief Scientific Officer from 2019 to 2020.
Dr. Currie received his doctorate degree from Wake Forest School of Medicine and undergraduate degree from the University of South Alabama.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
16/06/2026 676,900 ( 0.41% ) 2 M $ 31/05/2026

Mark Currie active positions

CompaniesPositionStart
IRONWOOD PHARMACEUTICALS, INC. Director/Board Member 01/01/2019
Director/Board Member 12/02/2020
Director/Board Member 01/02/2021
Director/Board Member -
Corporate Officer/Principal -

Former positions of Mark Currie

CompaniesPositionEnd
CYCLERION THERAPEUTICS, INC. President 01/12/2020
IRONWOOD PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/03/2019
Corporate Officer/Principal 01/08/2002
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Mark Currie's experience

Training of Mark Currie

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

50

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Commercial Services

Consumer Services

Health Technology

Process Industries

Consumer Services

Technology Services

Commercial Services

Health Services

Health Technology

Finance